Shanshan Wei

1.7k total citations · 1 hit paper
51 papers, 1.3k citations indexed

About

Shanshan Wei is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Shanshan Wei has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 10 papers in Oncology. Recurrent topics in Shanshan Wei's work include Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Inflammasome and immune disorders (4 papers) and Chromatography in Natural Products (3 papers). Shanshan Wei is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Inflammasome and immune disorders (4 papers) and Chromatography in Natural Products (3 papers). Shanshan Wei collaborates with scholars based in China, Thailand and United States. Shanshan Wei's co-authors include Bikui Zhang, Wenqun Li, Taoli Sun, Wanjun Ma, Chuanhao Jiang, Daxiong Xiang, Wen‐Qun Li, Weijun Peng, Jian Liu and Jiaqin Liu and has published in prestigious journals such as The Plant Journal, Journal of Experimental Botany and Frontiers in Immunology.

In The Last Decade

Shanshan Wei

48 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis

2021 164 citations Jiaqin Liu, Jian Liu et al. Drug Design Development and Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shanshan Wei China	16	605	236	218	150	141	51	1.3k
Wenqun Li China	22	712 1.2×	272 1.2×	176 0.8×	125 0.8×	161 1.1×	58	1.5k
Taoli Sun China	14	479 0.8×	134 0.6×	216 1.0×	120 0.8×	83 0.6×	29	1.1k
Shu‐Ju Wu Taiwan	18	474 0.8×	132 0.6×	153 0.7×	133 0.9×	94 0.7×	36	1.1k
Jianchang Qian China	23	719 1.2×	159 0.7×	222 1.0×	67 0.4×	190 1.3×	62	1.5k
Marthandam Asokan Shibu Taiwan	24	957 1.6×	220 0.9×	120 0.6×	182 1.2×	135 1.0×	98	1.9k
Mei-Lin Xie China	25	725 1.2×	151 0.6×	187 0.9×	290 1.9×	86 0.6×	93	1.8k
Ghada M. Suddеk Egypt	28	546 0.9×	117 0.5×	268 1.2×	185 1.2×	134 1.0×	77	1.8k
Guorong Fan China	20	543 0.9×	118 0.5×	149 0.7×	159 1.1×	180 1.3×	77	1.3k
Monisha Dhiman India	26	598 1.0×	165 0.7×	60 0.3×	123 0.8×	136 1.0×	65	1.7k
Yoichi Sunagawa Japan	21	911 1.5×	272 1.2×	74 0.3×	111 0.7×	132 0.9×	94	1.9k

Countries citing papers authored by Shanshan Wei

Since Specialization

Citations

This map shows the geographic impact of Shanshan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanshan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanshan Wei more than expected).

Fields of papers citing papers by Shanshan Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanshan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanshan Wei. The network helps show where Shanshan Wei may publish in the future.

Co-authorship network of co-authors of Shanshan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Shanshan Wei. A scholar is included among the top collaborators of Shanshan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanshan Wei. Shanshan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Jie, Xingyuan Hou, Ni Zhou, et al.. (2025). Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity. Cardiovascular Drugs and Therapy. 40(1). 65–80. 3 indexed citations

Wei, Shanshan, et al.. (2024). Parthenolide alleviates doxorubicin-induced cardiotoxicity via regulation of Cyp1a1 and Nppa and suppression of NLRP3 inflammasome. Journal of Traditional and Complementary Medicine. 15(7). 726–735.

Qi, Xiaoyu, Jianzhu Cao, Na Zhang, et al.. (2024). Case report: Modified transplantation for pediatric patients with pyruvate kinase deficiency. Frontiers in Immunology. 15. 1493398–1493398.

Li, Xiangyun, Shanshan Wei, Sa Liu, et al.. (2024). Trillin Protects Against Bleomycin-Induced Pulmonary Fibrosis via Suppressing Oxidative Stress and IL-1β/NLRP3 Inflammasome Positive Cycle. Natural Product Communications. 19(3). 2 indexed citations

Zhou, Ni, Nan Su, Shanshan Wei, et al.. (2024). Noncoding RNA-associated competing endogenous RNA networks in trastuzumab-induced cardiotoxicity. Non-coding RNA Research. 9(3). 744–758. 3 indexed citations

Zhou, Ni, Shanshan Wei, Taoli Sun, et al.. (2023). Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity. Frontiers in Pharmacology. 14. 1292088–1292088. 8 indexed citations

Hou, Zhenyan, Miao Yan, Huixiang Li, et al.. (2023). Variable p53/Nrf2 crosstalk contributes to triptolide-induced hepatotoxic process. Toxicology Letters. 379. 67–75. 4 indexed citations

Wei, Shanshan, et al.. (2023). Hyperoside Protects Trastuzumab-Induced Cardiotoxicity via Activating the PI3K/Akt Signaling Pathway. Cardiovascular Drugs and Therapy. 39(3). 481–490. 4 indexed citations

Xiao, Zijun, Shanshan Wei, Jie Huang, et al.. (2022). Noncoding RNA-Associated Competing Endogenous RNA Networks in Doxorubicin-Induced Cardiotoxicity. DNA and Cell Biology. 41(7). 657–670. 4 indexed citations

10.

Liu, Jiaqin, Jian Liu, Xiaoliang Tong, et al.. (2021). Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Drug Design Development and Therapy. Volume 15. 3255–3276. 164 indexed citations breakdown →

11.

Wei, Shanshan, et al.. (2021). Recent Progress in Environmental Toxins-Induced Cardiotoxicity and Protective Potential of Natural Products. Frontiers in Pharmacology. 12. 699193–699193. 18 indexed citations

12.

Ma, Lingman, Shanshan Wei, Xinyue Ye, et al.. (2020). Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis. Peptides. 130. 170334–170334. 9 indexed citations

13.

Wei, Shanshan, Wanjun Ma, Xiaohui Li, et al.. (2020). Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity. Cardiovascular Toxicology. 20(5). 507–519. 113 indexed citations

14.

Chen, Ying, Shanshan Wei, Yao Li, et al.. (2019). Identification and analysis of components in Shen-Fu-Shu granule extract and in rat plasma after oral administration by UPLC-ESI/Q-TOF-MS. Journal of Pharmaceutical and Biomedical Analysis. 169. 159–169. 15 indexed citations

15.

Jiang, Chuanhao, Taoli Sun, Daxiong Xiang, Shanshan Wei, & Wen‐Qun Li. (2018). Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.). Frontiers in Pharmacology. 9. 530–530. 197 indexed citations

16.

Wei, Shanshan, Taoli Sun, Jie Du, et al.. (2018). Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in�vitro. Oncology Reports. 40(6). 3213–3222. 72 indexed citations

17.

Zhang, Jing, Kai Han, Chunhui Wang, et al.. (2016). [Distribution of podophyllotoxin-loaded nanostructured lipid carriers after topical application on cervical mucosa in Tibet minipigs].. PubMed. 36(9). 1237–1241. 1 indexed citations

18.

Jia, Ning, et al.. (2016). The J-protein AtDjB1 is required for mitochondrial complex I activity and regulates growth and development through ROS-mediated auxin signalling. Journal of Experimental Botany. 67(11). 3481–3496. 11 indexed citations

19.

Wei, Shanshan, et al.. (2016). Traditional herbal formula Sini Powder extract produces antidepressant-like effects through stress-related mechanisms in rats. Chinese Journal of Natural Medicines. 14(8). 590–598. 14 indexed citations

20.

Zhao, Jiao, et al.. (2014). Separation and characterization of acetone-soluble phosphatidylcholine from Antarctic krill (Euphausia superba) oil. European Food Research and Technology. 238(6). 1023–1028. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact